Evidence map›Paper›PMID 26468347›Full record

ArticleGastroenterology and hepatology from bed to bench2015

Combination of erythromycin and propranolol for treatment of childhood cyclic vomiting syndrome: a novel regimen.

Mahmood Haghighat, Seyed Mohsen Dehghani, Iraj Shahramian, Mohammad Hadi Imanieh, Alireza Teimouri, Noor Mohammad Noori

Open access · greenAbstract read
In one paragraph

Article in Gastroenterology and hepatology from bed to bench, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Cyclic Vomiting Syndrome in Children.Frontiers in neurology · 2020
    Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Cyclic Vomiting Syndrome in Children.Current pain and headache reports · 2018
    Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Mahmood HaghighatGastroenterohepatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Seyed Mohsen DehghaniGastroenterohepatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Iraj ShahramianGastroenterohepatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Mohammad Hadi ImaniehGastroenterohepatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Alireza TeimouriChildren and Adolescents Health Research Center, Zahedan University of Medical Sciences, Zahedan, Iran.
Noor Mohammad NooriChildren and Adolescents Health Research Center, Zahedan University of Medical Sciences, Zahedan, Iran.
Shiraz University of Medical Sciences · IRZahedan University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimThis study aimed to evaluate the erythromycin efficacy in childhood cyclic vomiting syndrome.

backgroundCyclic vomiting syndrome (CVS) is an unusual cause of episodic emesis in children and erythromycin is an effective treatment. PATIENTS AND

methodsIn this prospective study, 301 patients with a final diagnosis of CVS enrolled in two separated groups. The first group received erythromycin for 7 days and propranolol for at least 9 months (n=155). The second group was treated with propranolol alone for at least 9 months (n=146). These two groups were compared for response to the treatment and the recurrence of symptoms after treatment completion. Relationship of response, recurrence, and characteristics of the disease was assessed.

resultsBoth groups showed a significant difference in terms of response to treatment (P=0.002), however the recurrence after treatment completion had no considerable difference (P=0.563). There was no relationship between CVS characteristics and these two items (response and recurrence).

conclusionIn our point of view, the addition of erythromycin to standard propranolol treatment can improve the response to treatment, although it has no significant effect on recurrence of CVS symptoms. We suggest the use of erythromycin for 7 days in addition to CVS standard therapy.

Indexed as

Cyclic Vomiting SyndromeErythromycinPropranololTherapy

Identifiers

PMID26468347
PMCPMC4600517
OpenAlexW2145679396

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.